167 related articles for article (PubMed ID: 24337364)
21. Nephrogenic diabetes insipidus with dilatation of bilateral renal pelvis, ureter and bladder.
Jin XD; Chen ZD; Cai SL; Chen SW
Scand J Urol Nephrol; 2009; 43(1):73-5. PubMed ID: 19037828
[TBL] [Abstract][Full Text] [Related]
22. Effect of hydrochlorothiazide and indomethacin treatment on renal function in nephrogenic diabetes insipidus.
Jakobsson B; Berg U
Acta Paediatr; 1994 May; 83(5):522-5. PubMed ID: 8086732
[TBL] [Abstract][Full Text] [Related]
23. Acquired nephrogenic diabetes insipidus.
Khanna A
Semin Nephrol; 2006 May; 26(3):244-8. PubMed ID: 16713497
[TBL] [Abstract][Full Text] [Related]
24. Acetazolamide Attenuates Lithium-Induced Nephrogenic Diabetes Insipidus.
de Groot T; Sinke AP; Kortenoeven ML; Alsady M; Baumgarten R; Devuyst O; Loffing J; Wetzels JF; Deen PM
J Am Soc Nephrol; 2016 Jul; 27(7):2082-91. PubMed ID: 26574046
[TBL] [Abstract][Full Text] [Related]
25. Treatment of severe lithium-induced polyuria with amiloride.
Kosten TR; Forrest JN
Am J Psychiatry; 1986 Dec; 143(12):1563-8. PubMed ID: 3538913
[TBL] [Abstract][Full Text] [Related]
26. Nephrogenic diabetes insipidus: a cause of severe nonobstructive urinary tract dilatation.
Stevens S; Brown BD; McGahan JP
J Ultrasound Med; 1995 Jul; 14(7):543-5. PubMed ID: 7563304
[No Abstract] [Full Text] [Related]
27. Comparative therapeutic benefit of indomethacin, hydrochlorothiazide, and acetyl-salicylic acid in a patient with nephrogenic diabetes insipidus.
Vierhapper H; Jörg J; Favre L; Vallotton MB; Waldhäusl W
Acta Endocrinol (Copenh); 1984 Jul; 106(3):311-6. PubMed ID: 6588700
[TBL] [Abstract][Full Text] [Related]
28. Response to indomethacin and hydrochlorothiazide in nephrogenic diabetes insipidus.
Monnens L; Jonkman A; Thomas C
Clin Sci (Lond); 1984 Jun; 66(6):709-15. PubMed ID: 6723207
[TBL] [Abstract][Full Text] [Related]
29. Congenital nephrogenic diabetes insipidus-vasopressin and prostaglandins in response to treatment with hydrochlorothiazide and indomethacin.
Rascher W; Rosendahl W; Henrichs IA; Maier R; Seyberth HW
Pediatr Nephrol; 1987 Jul; 1(3):485-90. PubMed ID: 3153321
[TBL] [Abstract][Full Text] [Related]
30. Hydrochlorothiazide-amiloride in the treatment of congenital nephrogenic diabetes insipidus.
Alon U; Chan JC
Am J Nephrol; 1985; 5(1):9-13. PubMed ID: 3970081
[TBL] [Abstract][Full Text] [Related]
31. Successful treatment with hydrochlorothiazide and amiloride in an infant with congenital nephrogenic diabetes insipidus.
Uyeki TM; Barry FL; Rosenthal SM; Mathias RS
Pediatr Nephrol; 1993 Oct; 7(5):554-6. PubMed ID: 8251321
[TBL] [Abstract][Full Text] [Related]
32. [Congenital nephrogenic diabetes insipidus].
Morin D; Delenne AL; Kervran A
Arch Pediatr; 2005 Jan; 12(1):59-66. PubMed ID: 15653057
[TBL] [Abstract][Full Text] [Related]
33. Novel AQP2 mutation causing congenital nephrogenic diabetes insipidus: challenges in management during infancy.
Rugpolmuang R; Deeb A; Hassan Y; Deekajorndech T; Shotelersuk V; Sahakitrungruang T
J Pediatr Endocrinol Metab; 2014 Jan; 27(1-2):193-7. PubMed ID: 23950570
[TBL] [Abstract][Full Text] [Related]
34. Treatment of congenital nephrogenic diabetes insipidus by hydrochlorothiazide and cyclooxygenase-2 inhibitor.
Pattaragarn A; Alon US
Pediatr Nephrol; 2003 Oct; 18(10):1073-6. PubMed ID: 12883974
[TBL] [Abstract][Full Text] [Related]
35. Indomethacin treatment in amphotericin B induced nephrogenic diabetes insipidus.
Höhler T; Teuber G; Wanitschke R; Meyer zum Büschenfeld KH
Clin Investig; 1994 Oct; 72(10):769-71. PubMed ID: 7865979
[TBL] [Abstract][Full Text] [Related]
36. Hydrochlorothiazide attenuates lithium-induced nephrogenic diabetes insipidus independently of the sodium-chloride cotransporter.
Sinke AP; Kortenoeven ML; de Groot T; Baumgarten R; Devuyst O; Wetzels JF; Loffing J; Deen PM
Am J Physiol Renal Physiol; 2014 Mar; 306(5):F525-33. PubMed ID: 24352504
[TBL] [Abstract][Full Text] [Related]
37. Antidiuretic effect of hydrochlorothiazide in lithium-induced nephrogenic diabetes insipidus is associated with upregulation of aquaporin-2, Na-Cl co-transporter, and epithelial sodium channel.
Kim GH; Lee JW; Oh YK; Chang HR; Joo KW; Na KY; Earm JH; Knepper MA; Han JS
J Am Soc Nephrol; 2004 Nov; 15(11):2836-43. PubMed ID: 15504936
[TBL] [Abstract][Full Text] [Related]
38. [Indomethacin therapy of children with nephrogenic diabetes insipidus].
Túri S; László A; Mérth I
Orv Hetil; 1980 Feb; 121(6):337-40. PubMed ID: 7366992
[No Abstract] [Full Text] [Related]
39. Nephrogenic diabetes insipidus.
Bockenhauer D; Bichet DG
Curr Opin Pediatr; 2017 Apr; 29(2):199-205. PubMed ID: 28134709
[TBL] [Abstract][Full Text] [Related]
40. Nephrogenic diabetes insipidus persisting 57 months after cessation of lithium carbonate therapy: report of a case and review of the literature.
Guirguis AF; Taylor HC
Endocr Pract; 2000; 6(4):324-8. PubMed ID: 11242610
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
